Reviva Pharmaceuticals Holdings Stock Today

RVPHW Stock  USD 0.22  0.03  12.00%   


0 of 100

Very Weak

Odds Of Distress

Over 81

Very High
Reviva Pharmaceuticals is selling for under 0.22 as of the 15th of July 2024; that is 12 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.16. Reviva Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Reviva Pharmaceuticals Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 15th of June 2024 and ending today, the 15th of July 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
18th of October 2018
Health Care
Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. More on Reviva Pharmaceuticals Holdings

Moving together with Reviva Stock

  0.72EQ EquilliumPairCorr

Moving against Reviva Stock

  0.72DRRX DurectPairCorr
  0.71DNLI Denali TherapeuticsPairCorr
  0.63VCYT VeracytePairCorr
  0.41VBIV VBI VaccinesPairCorr

Reviva Stock Highlights

Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Materials, Materials (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities18 M17.2 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total1.4 M806.7 K
Way Up
Slightly volatile
Total Assets18.2 M23.7 M
Way Down
Slightly volatile
Total Current Assets18.2 M23.7 M
Way Down
Slightly volatile
Reviva Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Reviva Pharmaceuticals' financial leverage. It provides some insight into what part of Reviva Pharmaceuticals' total assets is financed by creditors.
Reviva Pharmaceuticals Holdings has accumulated 17.98 M in total debt. Reviva Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Reviva Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

Net Income

(37.3 Million)
Reviva Pharmaceuticals Holdings (RVPHW) is traded on NASDAQ Exchange in USA. It is located in 10080 N. Wolfe Road, Cupertino, CA, United States, 95014 and employs 15 people. Reviva Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.81 M. Reviva Pharmaceuticals classifies itself under Pharmaceuticals sector and is part of Health Care industry. Reviva Pharmaceuticals Holdings has accumulated about 353.26 K in cash with (28.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Reviva Pharmaceuticals Probability Of Bankruptcy

Reviva Pharmaceuticals Historical Income Statement

At this time, Reviva Pharmaceuticals' Net Interest Income is fairly stable compared to the past year. Interest Income is likely to climb to about 523.9 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 212.7 K in 2024. View More Fundamentals

Reviva Stock Against Markets

Additional Tools for Reviva Stock Analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.